You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...
Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of aging,” Barzilai says. While not approved as anti-aging treatments ...
The FDA has continued to suspend food and drug items that people might typically buy. Here is a list of October food and drug items pulled off the shelves. It's good to be aware if you recently ...
The FDA’s accelerated approval program has helped shepherd nearly 300 new drugs to the market, providing access to these medicines an average of 3.2 years earlier than with traditional approvals, ...
News wrap: Key events that happened this week include, approval of resolution for statehood restoration in Jammu and Kashmir, BJP and NCP (SP) first list of candidates for Maharashtra Assembly ...
Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...
NEW YORK (PIX11) – The Federal Drug Administration issued a recall on ... an ingredient believed to be cancerous, according to the FDA. The agency labeled the recall as a Class II, meaning ...
Some food trends on social media are questionable, if not downright concerning (I'm looking at you, NyQuil chicken), but every once in a while, one comes along that’s actually good for you.
Jaguar Health, Inc. announced that Jaguar family company Napo Pharmaceuticals (Napo) has initiated the commercial launch of the FDA-approved oral mucositis prescription ... Oral mucositis can ...
Astellas’ approval timeline was derailed following the receipt of a complete response letter in January. The FDA rejected the drug over unresolved deficiencies uncovered during a pre-license ...
The move affects the accelerated approval for Trodelvy in advanced urothelial cancer patients who have previously received a PD-1/L1 inhibitor and chemotherapy. The drug’s other U.S. indications ...